Hedgehog Pathway Inhibitor class drugs

3 results
  • daurismo

    (glasdegib)
    Pfizer Laboratories Div Pfizer Inc
    DAURISMO is indicated for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients aged 75 or older, or those with comorbidities that prevent the use of intensive induction chemotherapy, when used in combination with low-dose cytarabine.
  • erivedge

    (vismodegib)
    Genentech, Inc.
    ERIVEDGE is indicated for adults with metastatic basal cell carcinoma or locally advanced basal cell carcinoma that has recurred after surgery, as well as those who are not candidates for surgery or radiation.
  • odomzo

    (sonidegib)
    Sun Pharmaceutical Industries, Inc.
    ODOMZO (sonidegib) is indicated for adult patients with locally advanced basal cell carcinoma (BCC) that has recurred after surgery or radiation therapy, or for those who are not suitable candidates for these treatments.